How does the gut microbiome influence immune checkpoint blockade therapy?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How does the gut microbiome influence immune checkpoint blockade therapy?

Published:2020-11-22 Issue:4 Volume:99 Page:361-372
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol. Cell Biol.

Author:

Almonte Andrew A¹^ORCID,Rangarajan Hareesha¹,Yip Desmond²^ORCID,Fahrer Aude M¹

Affiliation:

1. Division of Biomedical Science and Biochemistry, Research School of Biology Australian National University Acton ACT Australia

2. Department of Medical Oncology The Canberra Hospital and ANU Medical School Australian National University Garran ACT Australia

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imcb.12423

Reference65 articles.

1. Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

2. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

3. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

4. Pembrolizumab versus Ipilimumab in Advanced Melanoma

5. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical role of the gut microbiota in immune responses and cancer immunotherapy;Journal of Hematology & Oncology;2024-05-14

2. Gut microbiota and dietary intervention: affecting immunotherapy efficacy in non–small cell lung cancer;Frontiers in Immunology;2024-02-01

3. Early T Cell Infiltration Correlates with Anti-CTLA4 Treatment Response in Murine Cancer Models;The Journal of Immunology;2023-11-06

4. Effect of microbiome group on immune checkpoint inhibitors in treatment of gastrointestinal tumors;CHINESE J CANCER RES;2023

5. The progress on the relationship between gut microbiota and immune checkpoint blockade in tumors;Biotechnology and Genetic Engineering Reviews;2023-05-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3